Enter assignee name

Trademarks = 3

Forward Citations = 6

Loading Chart...

3 inventors (with patents filed for the assignee):

Lianhong Xu (6 out of 47 patents)

Zhi Hong (3 out of 3 patents)

Robert G Strickley (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12390484 - Adenosine derivative and pharmaceutical composition comprising the same (2025-08-19),

2. 12370208 - Adenosine derivative and pharmaceutical composition comprising the same (2025-07-29),

3. 12370200 - Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, and use thereof (2025-07-29),

4. 12257264 - Combination therapy for HIV with adenosine derivative and capsid inhibitors (2025-03-25),

5. 11890297 - Combination therapy for HIV with adenosine derivative and capsid inhibitors (2024-02-06),

6. 11793827 - Adenosine derivative and pharmaceutical composition comprising the same (2023-10-24),

Brii Biosciences, Inc. is a biopharmaceutical company focused on developing innovative therapies for infectious diseases and other serious conditions. The company leverages advanced science and technology to address unmet medical needs, particularly in the areas of viral infections and immune-mediated diseases. With a commitment to improving patient outcomes, Brii Biosciences aims to bring transformative treatments to market through strategic partnerships and a robust pipeline of drug candidates.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

6 Patents

#111 in Durham, NC

#951 in North Carolina

#43,823 in US

Durham, NC, United States of America

Brii Biosciences, Inc.

Forward Citations = 6

3 inventors:

Lianhong Xu (6 out of 47 patents)

Zhi Hong (3 out of 3 patents)

Robert G Strickley (1 out of 1 patent)

Please report any incorrect information to support@idiyas.com